Testing DAT1 and DRD4 Genes in Attention Deficit Hyperactivity Disorder Using a Wide Spectrum of Neurocognitive...

Area of Science:

• Neuroscience
• Genetics
• Child Psychology

Background:

• Attention-deficit/hyperactivity disorder (ADHD) presents significant heterogeneity in cognitive abilities.
• Dopaminergic genes, including DAT1 and DRD4, are implicated in ADHD pathophysiology.
• Understanding genetic influences on neurocognition is crucial for characterizing ADHD heterogeneity.

Purpose of the Study:

• To investigate the association between polymorphisms in DAT1 and DRD4 genes and neurocognitive performance in children and adolescents with ADHD.
• To identify specific genetic markers that correlate with executive functions in ADHD.
• To explore the role of dopaminergic gene variants in cognitive heterogeneity within ADHD.

Main Methods:

• Genotyping of VNTR polymorphisms in the 3' UTR of DAT1 and exon 3 of DRD4 in 336 participants (244 with ADHD, 92 controls).
• Neurocognitive performance was assessed using the CNS Vital Signs battery.
• Analysis of covariance (ANCOVA) was used to examine genotype-cognition associations, controlling for age and gender.

Main Results:

• Homozygosity for the DRD4 4-repeat allele was significantly associated with poorer cognitive flexibility and a trend towards impaired complex attention.
• No significant associations were found between DAT1 10R/10R homozygosity or DRD4 7-repeat allele carriage and reaction time, complex attention, or cognitive flexibility.
• DRD4 gene polymorphisms showed a stronger association with executive dysfunction than DAT1 polymorphisms.

Conclusions:

• The DRD4 gene, particularly the 4-repeat allele, may be a more significant genetic marker for executive dysfunction in ADHD compared to the DAT1 gene.
• Genetic influences on ADHD-related cognition are domain-specific and modest.
• Integrating genetic markers with cognitive endophenotypes is essential for a nuanced understanding of ADHD heterogeneity.